82585-90-8 Usage
Uses
Used in Pharmaceutical Industry:
(5-Amino-1,2-dihydro-3-(((4-methoxyphenyl)methylamino)methyl)pyrido (3,4-b)pyrazin-7-yl)-, carbamic acid, ethyl ester is used as a potential pharmaceutical agent for its ability to interact with biological targets due to the presence of the amino group and the pyrido ring system.
Used in Drug Development:
In the field of drug development, (5-Amino-1,2-dihydro-3-(((4-methoxyphenyl)methylamino)methyl)pyrido (3,4-b)pyrazin-7-yl)-, carbamic acid, ethyl ester is utilized as a compound with potential biological activity, which can be further investigated for its specific uses and effects on various diseases or conditions.
Used in Chemical Property Modification:
The carbamic acid and ethyl ester groups present in the compound can be used to modify its chemical properties, such as solubility or bioavailability, making it a candidate for the development of drugs with improved pharmacokinetic profiles.
Note: The specific applications and potential effects of (5-Amino-1,2-dihydro-3-(((4-methoxyphenyl)methylamino)methyl)pyrido (- 3,4-b)pyrazin-7-yl)-, carbamic acid, ethyl ester would require further research and investigation to be fully understood and realized.
Check Digit Verification of cas no
The CAS Registry Mumber 82585-90-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,5,8 and 5 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 82585-90:
(7*8)+(6*2)+(5*5)+(4*8)+(3*5)+(2*9)+(1*0)=158
158 % 10 = 8
So 82585-90-8 is a valid CAS Registry Number.
InChI:InChI=1/C19H24N6O3/c1-4-28-19(26)24-16-9-15-17(18(20)23-16)22-12(10-21-15)11-25(2)13-5-7-14(27-3)8-6-13/h5-9,21H,4,10-11H2,1-3H3,(H3,20,23,24,26)
82585-90-8Relevant academic research and scientific papers
1,2-dihydropyrido[3,4-b]pyrazines
-
, (2008/06/13)
1,2-Dihydropyrido[3,4-b]pyrazines are provided which possess anticancer activity. The compounds have the structure: STR1 wherein Y is CH2 or N(CH3); R1 is a lower alkyl group; e.g., an alkyl group containing up to six carb
New Anticancer Agents: Synthesis of 1,2-Dihydropyridopyrizines (1-Deaza-7,8-dihydropteridines)
Temple, Carroll,Wheeler, Glynn P.,Elliott, Robert D.,Rose, Jerry D.,Kussner, Conrad L.,et al.
, p. 1045 - 1050 (2007/10/02)
Reaction of α-aminoacetophenone oximes (2) with ethyl 6-amino-4-chloro-5-nitropyridine-2-carbamate (1) gave ethyl 6-amino-5-nitro-4-pyridine-2-carbamate oximes (3), which were hydrolyzed under acidic conditions to give the corresponding ketones (4).Related pyridines substituted with keto side chain were prepared from 1 and 1,3-diaminopropanone oximes and by oxidation of the side-chain hydroxy group of ethyl 6-amino-4-amino>-5-nitropyridine-7-carbamates (6).Catalytic hydrogenation of the nitro group of 4 over Raney nickel in a large volume of ethanol gave the 1-deaza-7,8-dihydropteridines (7).Several of the oximes 3 were successfully hydrogenated to give 7 directly.The resulting 1-deaza-7,8-dihydropteridines showed potent cytotoxicity against cultured L1210 cells and significant anticancer activity against lymphocytic leukemia P-388 in mice.THese biological activities are attributed to the accumulation of cells at mitosis.
